Literature DB >> 12372533

P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease.

E Scott Priestley1, Indawati De Lucca, Bahman Ghavimi, Susan Erickson-Viitanen, Carl P Decicco.   

Abstract

A series of peptide boronic acids containing extended, hydrophobic P1 residues was prepared to probe the shallow, hydrophobic S1 region of HCV NS3 protease. The p-trifluoromethylphenethyl P1 substituent was identified as optimal with respect to inhibitor potency for NS3 and selectivity against elastase and chymotrypsin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372533     DOI: 10.1016/s0960-894x(02)00682-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Branched peptide boronic acids (BPBAs): a novel mode of binding towards RNA.

Authors:  Wenyu Zhang; David I Bryson; Jason B Crumpton; Jessica Wynn; Webster L Santos
Journal:  Chem Commun (Camb)       Date:  2013-03-25       Impact factor: 6.222

3.  HIV-1 drug discovery: targeting folded RNA structures with branched peptides.

Authors:  Jessica E Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2015-06-07       Impact factor: 3.876

4.  Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases.

Authors:  Nikos Kühl; Johannes Lang; Mila M Leuthold; Christian D Klein
Journal:  Eur J Med Chem       Date:  2022-07-11       Impact factor: 7.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.